Cytomegalovirus (CMV) seroprevalence in Japanese blood donors and high detection frequency of CMV DNA in elderly donors
Author:
Affiliation:
1. Blood Service Headquarters; Japanese Red Cross; Tokyo; Japan
2. Central Blood Institute; Japanese Red Cross; Tokyo; Japan
3. Japanese Red Cross Tohoku Block Blood Center; Sendai; Japan
Publisher
Wiley
Subject
Hematology,Immunology,Immunology and Allergy
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/trf.12390/fullpdf
Reference33 articles.
1. Indications for the use of cytomegalovirus-seronegative blood products;Preiksaitis;Transfus Med Rev,1991
2. A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant;Bowden;Blood,1995
3. The cytomegalovirus-“safe” blood product: is leukoreduction equivalent to antibody screening?;Preiksaitis;Transfus Med Rev,2000
4. Is white blood cell reduction equivalent to antibody screening in preventing transmission of cytomegalovirus by transfusion? A review of the literature and meta-analysis;Vamvakas;Transfus Med Rev,2005
5. Survey of current practice for prevention of transfusion-transmitted cytomegalovirus in the United States: leucoreduction vs. cytomegalovirus-seronegative;Smith;Vox Sang,2010
Cited by 73 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cytomegalovirus Reactivation during Elotuzumab Therapy in Patients with Multiple Myeloma;Acta Haematologica;2024-04-24
2. Estimated cytomegalovirus seroprevalence in the general population of the United States and Canada;Journal of Medical Virology;2024-03
3. The effect of infectious diseases on lung transplantation in Japan;Journal of Thoracic Disease;2024-02
4. Association between cytomegalovirus seropositivity and all‐cause mortality: An original cohort study;Journal of Medical Virology;2024-01-31
5. Clinical impact of cytomegalovirus reactivation and immune reconstitution after allogeneic hematopoietic cell transplantation;Japanese Journal of Transplantation and Cellular Therapy;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3